bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.16.649069

HilE mediates motility thermoregulation in typhoidal Salmonella serovars at elevated physiological temperatures

Abstract

Salmonella enterica is a diverse bacterial pathogen consisting of both typhoidal and nontyphoidal clinically distinct serovars. While typhoidal serovars cause in humans a systemic life-threatening enteric fever, nontyphoidal Salmonella (NTS) usually provoke a localized self-limiting gastroenteritis. Factors responsible for the different diseases caused by distinct Salmonella serovars are still poorly understood. Here, we show that at elevated physiological temperature, manifested during enteric fever (39-40{degrees}C), the transcription of the flagellar regulon, its protein translation, and flagella-mediated motility are all repressed in the typhoidal serovar, S. Paratyphi A (SPA). In contrast, the NTS representative serovar, S. Typhimurium, maintains similar or even higher levels of flagellar genes transcription, translation, and motility at 40{degrees}C relative to 37{degrees}C. By using a temperature-responsive flagellar reporter system in conjunction with a dense transposon mutagenesis screen we found that under elevated temperature, HilE negatively regulates SPA motility in a HilD-dependent manner. Since HilD is required for the transcriptional activation of FlhDC, the master regulator of the Salmonella flagellar-chemotaxis regulon, null deletion of hilE leads to motility upregulation at elevated temperature and the loss of motility thermoregulation in SPA. Interestingly, the absence of HilE also leads to a hyper-uptake of SPA by THP- 1 human macrophages at 40{degrees}C, but not at 37{degrees}C. Moreover, we show that a HilE-mediated motility thermoregulation is common to other typhoidal serovars, including S. Typhi and S. Sendai, but not to S. Paratyphi B, nor to various NTS serovars. Based on these results, we propose that HilE plays a unique role in motility thermoregulation in typhoidal Salmonella in a way that may restrain systemic dissemination of the pathogen via professional phagocytes, during the acute phase of enteric fever. AUTHOR SUMMARYDespite high genetic similarity, typhoidal and nontyphoidal Salmonella (NTS) strains of the single species Salmonella enterica cause in humans different diseases manifested as life-threatening enteric fever and short-term gastroenteritis, respectively. Currently, we are still ignorant about bacterial factors shaping the different lifestyles of typhoidal vs. NTS strains. Here we characterized differences in the regulation of Salmonella motility, which is an important virulence-associated phenotype, in response to changes in temperature, between typhoidal and NTS. We found that at elevated temperature, equivalent to the body temperature during enteric fever (39-40{degrees}C), the motility of typhoidal Salmonella, but not that of NTS is strongly repressed, by the negative regulator HilE in a HilD-dependent manner. Moreover, we demonstrate that HilE plays a previously unknown role in the interaction of S. Paratyphi A with phagocytic cells, as the absence of HilE caused enhanced uptake of this pathogen by human macrophages at elevated physiological temperature, but not at 37{degrees}C. Since motility thermoregulation by HilE was found in three different typhoidal serovars, but not in NTS, we hypothesize that motility regulation affects the interactions of Salmonella with its host and differences in its regulation contribute to the distinct pathogenicity of typhoidal vs. NTS strains.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Shem-Tov, R., Gal-Mor, O.. 2025-04-16. HilE mediates motility thermoregulation in typhoidal Salmonella serovars at elevated physiological temperatures. https://doi.org/10.1101/2025.04.16.649069

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗